Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022

M Arock; G Hoermann; Karl Sotlar; O Hermine; WR Sperr; K Hartmann; K Brockow; C Akin; M Triggiani; S Broesby-Olsen; A Reiter; J Gotlib; HP Horny; A Orfao; DD Metcalfe; P Valent

doi:10.1016/j.jaci.2022.04.004

Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022

M Arock, G Hoermann, Karl Sotlar (Co-Autor/-in), O Hermine, WR Sperr, K Hartmann, K Brockow, C Akin, M Triggiani, S Broesby-Olsen, A Reiter, J Gotlib, HP Horny, A Orfao, DD Metcalfe, P Valent

Universitätsinstitut für Pathologie

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

20 Quellenangaben (Web of Science)

Originalsprache	Englisch
Seiten (von - bis)	1855-1865
Fachzeitschrift	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
Jahrgang	149
Ausgabenummer	6
DOIs	https://doi.org/10.1016/j.jaci.2022.04.004
Publikationsstatus	Veröffentlicht - 2022

Zugriff auf Dokument

10.1016/j.jaci.2022.04.004

Dieses zitieren

Arock, M., Hoermann, G., Sotlar, K., Hermine, O., Sperr, WR., Hartmann, K., Brockow, K., Akin, C., Triggiani, M., Broesby-Olsen, S., Reiter, A., Gotlib, J., Horny, HP., Orfao, A., Metcalfe, DD., & Valent, P. (2022). Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , 149(6), 1855-1865. https://doi.org/10.1016/j.jaci.2022.04.004

Arock, M ; Hoermann, G ; Sotlar, Karl et al. / Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022. in: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 2022 ; Jahrgang 149, Nr. 6. S. 1855-1865.

@article{0250cedda0e4404a8280e13caba40b46,

title = "Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022",

keywords = "ADVANCED SYSTEMIC MASTOCYTOSIS, C-KIT MUTATION, BONE-MARROW, PEDIATRIC MASTOCYTOSIS, TYROSINE KINASE, D816V, DIAGNOSIS, DISEASE, SURVIVAL, LINEAGE",

author = "M Arock and G Hoermann and Karl Sotlar and O Hermine and WR Sperr and K Hartmann and K Brockow and C Akin and M Triggiani and S Broesby-Olsen and A Reiter and J Gotlib and HP Horny and A Orfao and DD Metcalfe and P Valent",

note = "Sotlar: Institute of Pathology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria",

year = "2022",

doi = "10.1016/j.jaci.2022.04.004",

language = "English",

volume = "149",

pages = "1855--1865",

journal = "JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY ",

issn = "0091-6749",

number = "6",

}

Arock, M, Hoermann, G, Sotlar, K, Hermine, O, Sperr, WR, Hartmann, K, Brockow, K, Akin, C, Triggiani, M, Broesby-Olsen, S, Reiter, A, Gotlib, J, Horny, HP, Orfao, A, Metcalfe, DD & Valent, P 2022, 'Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022', JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , Jg. 149, Nr. 6, S. 1855-1865. https://doi.org/10.1016/j.jaci.2022.04.004

Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022. / Arock, M; Hoermann, G; Sotlar, Karl (Co-Autor/-in) et al.
in: JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY , Jahrgang 149, Nr. 6, 2022, S. 1855-1865.

Publikation: Beitrag in Fachzeitschrift › Übersichtsarbeit › Begutachtung

TY - JOUR

T1 - Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022

AU - Arock, M

AU - Hoermann, G

AU - Sotlar, Karl

AU - Hermine, O

AU - Sperr, WR

AU - Hartmann, K

AU - Brockow, K

AU - Akin, C

AU - Triggiani, M

AU - Broesby-Olsen, S

AU - Reiter, A

AU - Gotlib, J

AU - Horny, HP

AU - Orfao, A

AU - Metcalfe, DD

AU - Valent, P

N1 - Sotlar: Institute of Pathology, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - ADVANCED SYSTEMIC MASTOCYTOSIS

KW - C-KIT MUTATION

KW - BONE-MARROW

KW - PEDIATRIC MASTOCYTOSIS

KW - TYROSINE KINASE

KW - D816V

KW - DIAGNOSIS

KW - DISEASE

KW - SURVIVAL

KW - LINEAGE

U2 - 10.1016/j.jaci.2022.04.004

DO - 10.1016/j.jaci.2022.04.004

M3 - Review article

C2 - 35430191

SN - 0091-6749

VL - 149

SP - 1855

EP - 1865

JO - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

JF - JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

IS - 6

ER -

Arock M, Hoermann G, Sotlar K, Hermine O, Sperr WR, Hartmann K et al. Clinical impact and proposed application of molecular markers, genetic variants, and cytogenetic analysis in mast cell neoplasms: Status 2022. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY . 2022;149(6):1855-1865. doi: 10.1016/j.jaci.2022.04.004